Prelude Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,700
| Closed | -$11K | – | 1843 |
|
|
2020
Q3 | $11K | Sell |
2,700
-100
| -4% | -$407 | ﹤0.01% | 1096 |
|
|
2020
Q2 | $9K | Buy |
+2,800
| New | +$9K | ﹤0.01% | 1095 |
|
|
2020
Q1 | – | Sell |
-6,699
| Closed | -$21K | – | 1844 |
|
|
2019
Q4 | $21K | Sell |
6,699
-6,455
| -49% | -$20.2K | ﹤0.01% | 1157 |
|
|
2019
Q3 | $59K | Buy |
13,154
+952
| +8% | +$4.27K | ﹤0.01% | 719 |
|
|
2019
Q2 | $58K | Buy |
12,202
+5,847
| +92% | +$27.8K | ﹤0.01% | 757 |
|
|
2019
Q1 | $35K | Buy |
+6,355
| New | +$35K | ﹤0.01% | 872 |
|
|
2018
Q2 | – | Sell |
-5,847
| Closed | -$37K | – | 1863 |
|
|
2018
Q1 | $37K | Buy |
+5,847
| New | +$37K | ﹤0.01% | 1014 |
|
|
2015
Q2 | – | Sell |
-534
| Closed | -$50K | – | 2157 |
|
|
2015
Q1 | $50K | Buy |
534
+13
| +2% | +$1.22K | 0.01% | 1234 |
|
|
2014
Q4 | $46K | Sell |
521
-2,184
| -81% | -$193K | 0.01% | 1195 |
|
|
2014
Q3 | $187K | Buy |
2,705
+1,434
| +113% | +$99.1K | 0.03% | 674 |
|
|
2014
Q2 | $73K | Buy |
+1,271
| New | +$73K | 0.01% | 1102 |
|